| Biological Sciences | Lifetime | 772 | GB 76 | 99.91 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 66 | GB 4 | 99.82 |
| Epidemiology | Lifetime | 134 | GB 9 | 99.82 |
| Molecular Biology | Lifetime | 488 | GB 30 | 99.76 |
| Immunology | Lifetime | 180 | GB 14 | 99.60 |
| Virology | Lifetime | 68 | GB 6 | 98.98 |
| Infectious Diseases | Lifetime | 492 | GB 41 | 98.09 |
| Infectious Diseases | 2021-2025 | 60 | GB 7 | 99.08 |
| Epidemiology | 2021-2025 | 430 | GB 38 | 96.25 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 433 | GB 31 | 91.11 |
| Virology | 2021-2025 | 97 | GB 7 | 83.21 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 2 | GB 1 | 99.98 |
| Glycosylation and Glycoproteins Research | Lifetime | 11 | GB 1 | 99.88 |
| Influenza Virus Research Studies | Lifetime | 9 | GB 1 | 99.91 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 67 | GB 4 | 99.64 |
| HIV Research and Treatment | Lifetime | 67 | GB 5 | 99.74 |
| Respiratory viral infections research | Lifetime | 52 | GB 6 | 99.72 |
| Immune Cell Function and Interaction | Lifetime | 156 | GB 11 | 99.79 |
| COVID-19 Clinical Research Studies | Lifetime | 227 | GB 24 | 98.91 |
| T-cell and B-cell Immunology | Lifetime | 251 | GB 19 | 99.47 |
| Immunotherapy and Immune Responses | Lifetime | 385 | GB 23 | 99.34 |
| vaccines and immunoinformatics approaches | Lifetime | 59 | GB 2 | 99.13 |
| Enzyme Structure and Function | Lifetime | 147 | GB 14 | 99.26 |
| Immune Response and Inflammation | Lifetime | 281 | GB 21 | 99.26 |
| RNA and protein synthesis mechanisms | Lifetime | 498 | GB 35 | 98.97 |
| Protein purification and stability | Lifetime | 151 | GB 7 | 98.22 |
| Protein Structure and Dynamics | Lifetime | 349 | GB 30 | 98.64 |
| Biochemical and Molecular Research | Lifetime | 440 | GB 37 | 97.14 |
| HIV/AIDS drug development and treatment | Lifetime | 916 | GB 52 | 97.23 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 21 | GB 2 | 99.40 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 82 | GB 9 | 99.54 |
| COVID-19 Clinical Research Studies | 2021-2025 | 372 | GB 50 | 98.21 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 122 | GB 4 | 96.92 |
| Influenza Virus Research Studies | 2021-2025 | 101 | GB 11 | 96.82 |
| vaccines and immunoinformatics approaches | 2021-2025 | 60 | GB 3 | 95.90 |
| HIV Research and Treatment | 2021-2025 | 334 | GB 14 | 93.65 |
| Animal Virus Infections Studies | 2021-2025 | 506 | GB 14 | 89.79 |
| Glycosylation and Glycoproteins Research | 2021-2025 | 807 | GB 24 | 82.39 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 517 | GB 26 | 54.79 |